EUCANIMAGE Project

EuCanImage is a 4-year research project building a European cancer imaging platform that will enhance the potential of Artificial Intelligence in oncology. The project is funded by the European Union’s Horizon 2020 research and innovation programme under grant agreement No 952103.

EuCanImage will build and demonstrate a GDPR-compliant and scalable platform for leveraging large-scale, high-quality and interoperable cancer imaging datasets adequately linked to biological and health cancer data. The platform will integrate advanced capabilities and new standards to develop and validate integrative decision support systems for precision oncology with increased clinical trust and adoption. The project consortium is an experienced and ambitious academic-industrial-clinical partnership, with a proven track record in data management, responsible data sharing, cancer imaging research, and AI for personalised medicine.

Radiomics will develop and validate an AI solution for semi-automatic liver cancer detection, classification, and reporting from medical images (WP2). Furthermore, Radiomics will leverage its cost-benefit analysis tool and adapt it for the three cancer domains in EuCanImage (liver, colorectal, breast). Additionally, Radiomics brings extensive knowhow on commercialization and entrepreneurship to the consortium.

• University of Barcelona (Coordinator), Spain
• Maastricht University, Netherlands
• Erasmus University Medical Center Rotterdam, Netherlands
• Barcelona Supercomputing Center, Spain
• Centre for Genomic Regulation, Spain
• University of Arkansas for Medical Studies, United States of America
• Biobanks and Biomolecular Resources Research Infrastructure Consortium (BBMRI-ERIC), Austria
• University of the Basque Country, Spain
• Lynkeus, Italy
• Collective Minds Radiology AB, Sweden
• Radiomics, Belgium
• Siemens Helathcare  GMBH, Germany
• European Institute for Biomedical Imaging Research (EIBIR), Austria
• European Society of Oncologic Imaging (ESOI), Austria
• European Association for Cancer Research, United Kingdom
• University of Pisa, Italy
• Fundacio Clinic per a la Recerca Biomedica (FCRB), Spain
• UMEA University, Sweden
• Medical University of Gdanks, Poland
• Hospital of Lithuanian University of Health Sciences Kaunas Clinics, Lithuania